Circulation, Vol 144, Issue Suppl_1
For about 8 years, Dr. Steven Gundry had been monitoring a group of 566 patients with a PULS (Protein Unstable Lesion Signature) test, and they averaged an 11% risk of having an acute coronary event, such as a heart attack, within 5 years. (After all, these were his patients and he is a cardiologist, so we can expect their risk to be elevated).
When Dr. Gundry tested these patients again after they had taken the Covid-19 vaccine, he found their average risk had more than doubled to 25%.
Dr. Mercola’s November article about these findings can be found here. For your convenience, I will paste below his “Story at a Glance.”
STORY AT-A-GLANCE
Using the PULS cardiac test, researchers have found Pfizer and Moderna mRNA COVID shots dramatically increase biomarkers associated with thrombosis, cardiomyopathy and other vascular events following vaccination
Pre- and post-injection PULS tests for 566 patients were compared. On average, their PULS scores went from an 11% five-year risk for acute coronary syndrome, to a more than double, 25%, five-year risk
Those who got the injection for fear that COVID-19 might adversely affect their heart now face the grim reality that they’ve exchanged a potential risk for a more certain one
Another paper details how the mRNA shot can cause thrombocytopenia (low platelet count) through a mechanism that involves the activation of platelets by antibodies against the spike protein (anti-spike antibodies)
A mystery that remains to be solved is why only certain people with antibodies to the spike protein (anti-spike antibodies) go on to develop symptoms of platelet activation and thrombocytopenia. One hypothesis is that only a subset of the anti-spike antibodies formed after vaccination can activate platelets and cause thrombocytopenia
Dr. Gundry concluded: “the mRNA vacs dramatically increase inflammation on the endothelium and T-cell infiltration of cardiac muscle and may account for the observations of increased thrombosis, cardiomyopathy, and other vascular events following vaccination.”
Abstract || Dr. Mercola’s article on this subject
Related papers referred to by Dr. Mercola in his paper above:
-
- SARS-CoV-2 spike vaccine-induced thrombocytopenia
- Mayo Clinic: Acute Coronary Syndrome
- Appelbaum 2021: SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia
- Lee 2021: Thrombocytopenia following Pfizer and Moderna SARS‐CoV‐2 vaccination
- VAERS-Nov-12-2021
- Sucharit Bhakdi, 2021: Letter to European Medicines Agency
NOTE: There is an “expression of concern” on Dr. Gundry’s abstract. I tracked it down, and it seems to be a complaint that the abstract contains typographical errors and uses anecdotal information. It is true that there is one typo, as PULS is spelled “PLUS” when first introduced, but I have seen far worse in published papers. Later, the author wrote “pts” for “patients” but the intent is certainly clear. There are no other typos. I cannot imagine why testing a group of patients before an intervention (the vaccine) and again afterwards would be called “anecdotal.” While it is not a double-blind study, it is certainly a valid design, called quasi-experimental or trend analysis. My best guess is that somebody didn’t like the results — which are admittedly horrific — and is trying to downgrade the study.
